NanoHybrids

company

About

NanoHybrids harnesses the power of nanotechnology and molecular targeting.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$149.99K
Industries
Clinical Trials,Medical Device,Nanotechnology
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

As nanotechnology rapidly expands into the realms of medicine, there is an unmet need for “smart” nanoparticles capable of homing in on diseased tissue while leaving healthy cells intact. When targeted to specific biomarkers, these nanoparticles can provide critical information about the biology of the disease in the context of the anatomy both in vitro and in vivo.

Their nano-sized contrast agents can enhance biomedical imaging techniques by interacting specifically with diseased cells and allowing for real time imaging of functional biology. Their products can potentially be employed in a wide variety of applications including optical biomedical imaging, microscopy, molecular diagnostics and theranostic approaches.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$149.99K
NanoHybrids has raised a total of $149.99K in funding over 2 rounds. Their latest funding was raised on Dec 21, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 21, 2015 Grant $149.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NanoHybrids is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant